Speaker(s):
Amitpal Johal MD, Gastroenterology Department Chair, has nothing to disclose.
Harshit Khara, MD, Gastroenterology Director, Geisinger Danville, has nothing to disclose
Moderator(s):
Leonie Vachon, CRNP, Chief Nurse Practitioner Geisinger Gastroenterology Western Region - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Discuss the Geisinger Health System Policy on prescribing GLP-1 Inhibitors and identify alternative medications for weight loss.
- Review the patient selection, indications, and applications of Endoscopic Sleeve Gastroplasty (ESG)
- Review the procedural details and clinical outcomes of ESG
- Review the patient pathways for ESG at Geisinger as part of the comprehensive weight management program
- Review the role of ESG as bridge therapy in the management of hepatology, nephrology, transplant, and orthopedic patients
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Karla Leschinsky, PA-C; Leonie Vachon, CRNP; Lorella Thomas, CRNP; Desiree Adams, RN and Alyssa Jones, PharmD have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPPA compliant.
Commercial Support for this Session
None
Session date:
10/02/2024 - 12:00pm to 1:00pm EDT
Location:
Virtual Activity using Microsoft Teams
United States
See map: Google Maps
Add to calendar:
- 1.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 ANCC
- 1.00 Participation Credit